MREO
Mereo Biopharma·NASDAQ
--
--(--)
--
--(--)
MREO fundamentals
Mereo Biopharma (MREO) released its earnings on Nov 10, 2025: revenue was 300.00K (YoY --), missed estimates; EPS was -0.01 (YoY +50.00%), missed estimates.
Revenue / YoY
300.00K
--
EPS / YoY
-0.01
+50.00%
Report date
Nov 10, 2025
EPS
Actual | -0.02 | -0.01 | -0.02 | -0.02 | -0.01 | ||||||
Forecast | -0.01 | -0.0129 | -0.0071 | -0.0117 | -0.0057 | ||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | +22.48% | -181.69% | -70.94% | -75.44% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 500.00K | 300.00K |
Forecast | -- | -- | -- | -- | -- | -- | 0 | 36.25M | 26.88M | 0 | 11.67M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -100.00% | 0.00% | -97.43% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Mereo Biopharma next quarter?What is Mereo Biopharma's gross profit margin?What were the key takeaways from Mereo Biopharma's earnings call?What does Mereo Biopharma do and what are its main business segments?What is Mereo Biopharma's latest dividend and current dividend yield?What were the key takeaways from Mereo Biopharma’s earnings call?What is the revenue and EPS growth rate for Mereo Biopharma year over year?Did Mereo Biopharma beat or miss consensus estimates last quarter?
